Business Wire

MA-4AIR

22.5.2023 16:06:28 CEST | Business Wire | Press release

Share
4AIR Launches Assure SAF Registry to Track and Validate Sustainable Aviation Fuel

4AIR, which helps companies offset their emissions, use Sustainable Aviation Fuel (SAF), and drive technological change, today announced the launch of Assure SAF Registry, a blockchain-based web registry designed to document, trace and account for the sustainability attributes of Sustainable Aviation Fuel (SAF).

The Assure SAF Registry provides complete transparency about the type of SAF purchased, the feedstock used, the blend of the fuel, and any sustainability certifications earned or regulatory programs for which the fuel may be eligible. The registry is designed for both physical and book and claim supply chains of SAF and will simplify inventory accounting and prevent double-counting of benefits. All while protecting suppliers’ commercially sensitive and confidential data. By uniquely addressing a SAF tracking need for fuel suppliers, FBOs, airlines, and operators, within the physical supply chain, the registry can unlock the opportunity for a robust book and claim tracking system as well.

“Most SAF today comes from one to two different feedstocks with a narrow range of blends. As SAF expands to new feedstocks and higher blends, transparency about the fuel and where it came from will be critical in efforts to scale its use across the industry, including both business and commercial aviation,” said Kennedy Ricci, President of 4AIR. “Assure SAF Registry will provide a key piece of infrastructure for the transparent scale-up of SAF in aviation, providing transparency to emission claims around SAF while maximizing the value for the operator.”

Leveraging the expertise gained through the documentation of 5.8 million gallons of SAF over the last 2 years, 4AIR created a registry that addresses the most challenging pain points found when tracing the usage of SAF. Usually, SAF is co-mingled in airport pipelines or fuel farms under mass balance or book and claim chains of custody, making it laborious to document, particularly when trying to retain information for regulatory claims from the use of the fuel.

The Assure SAF Registry serializes each unit of fuel and is linked to a specific owner and batch of SAF. This ensures that only one owner can ever claim a specific quantity of fuel and that sustainability characteristics are consistently and accurately communicated through various owners, providing confidence in the ownership and emissions accounting up and down the SAF supply chain.

Pilot programs will help the platform to automate integrations with supplier systems, eliminating the need for much of the manual reporting and accounting. In addition, a pilot program with the Roundtable on Sustainable Biomaterials (RSB) will seek recognition within the RSB Book & Claim System and work towards ecosystem harmonization and a credible claim for customers.

About 4AIR

4AIR is an aviation industry pioneer offering sustainability solutions beyond just simple carbon neutrality. Its industry-first framework seeks to address climate impacts of all types and provides a simplified and verifiable path for aviation industry participants to achieve meaningful aircraft emissions counteraction and reduction. The 4AIR framework offers four levels, each with specific, science-based goals, independently verified results, and progressively greater impacts on sustainability that make it easy for private aviation users to pursue sustainability through access to carbon markets, use of Sustainable Aviation Fuel, support for new technologies and other strategies. For more information, visit us at www.4air.aero.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230522005450/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release

Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release

- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur

Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye